DHC42201
Research Grade Rinucumab
Größe
£200.00
- SKU:
- DHC42201
- Zusätzliche Namen:
- REGN-2176, REGN-2176-3 (combination of aflibercept and ricunumab), REGN2176, CAS: 1569263-06-4
- Physischer Zustand:
- Liquid
- Reinheit:
- >95%
- Aufreinigung:
- Protein A/G purified from cell culture supernatant.
- Lagerbedingungen:
- -20[o]C Avoid freeze/thaw cycles., 2-8[o]C Avoid freeze/thaw cycles., -70[o]C Avoid freeze/thaw cycles.
- Hersteller:
- AntibodySystems
- Host:
- Human
- Reaktivitäten:
- Human
- Buffer:
- 0.01M PBS, pH 7.4.
- Immunogen:
- Beta-type platelet-derived growth factor receptor, Beta platelet-derived growth factor receptor, CD140b, Platelet-derived growth factor receptor 1, PDGFRB, PDGF-R-beta, Platelet-derived growth factor receptor beta, CD140 antigen-like family member B, PDGFR-1, PDGFR1, PDGFR-beta, PDGFR
- Klon:
- Rinucumab
- Uniprot:
- P09619
- Synonyme:
- Activated tyrosine kinase PDGFRB;Beta platelet-derived growth factor receptor;beta-type platelet-derived growth factor receptor;CD140 antigen-like family member B;CD140B;IBGC4;IMF1;JTK12;KOGS;NDEL1-PDGFRB;PDGF-R-beta;PDGFR;PDGFR-1;PDGFR-beta;PDGFR1;PENTT;platelet-derived growth factor receptor 1;platelet-derived growth factor receptor beta;platelet-derived growth factor receptor, beta polypeptide
- Versandbedingungen:
- Blue Ice